DeepGene Transformer: Transformer for the gene expression-based classification of cancer subtypes

Cancer and its subtypes constitute approximately 30% of all causes of death globally and display a wide range of heterogeneity in terms of clinical and molecular responses to therapy. Molecular subtyping has enabled the use of precision medicine to overcome these challenges and provide significant biological insights to predict prognosis and improve clinical decision-making. Over the past decade, conventional machine learning (ML) and deep learning (DL) algorithms have been widely espoused for the classification of cancer subtypes from gene expression datasets. However, these methods are potentially biased toward the identification of cancer biomarkers. Hence, an end-to-end deep learning approach, DeepGene Transformer, is proposed which addresses the complexity of high-dimensional gene expression with a multi-head self-attention module by identifying relevant biomarkers across multiple cancer subtypes without requiring feature selection as a pre-requisite for the current classification algorithms. Comparative analysis reveals that the proposed DeepGene Transformer outperformed the commonly used traditional and state-of-the-art classification algorithms and can be considered an efficient approach for classifying cancer and its subtypes, indicating that any improvement in deep learning models in computational biologists can be reflected well in this domain as well.